FDA Adverse Event Injury Summary report: N

PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2061369 · Received April 18, 2011

Report

Report Number
2024168-2011-02704
Event Type
Injury
Date Received
April 18, 2011
Date of Event
March 22, 2011
Report Date
March 24, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. GUIDE WIRE: ALL STAR, WHISPER EXTRA SUPPORT, PROWATER. YOU ARE RECEIVING THIS MDR REPORT FROM ABBOTT VASCULAR BECAUSE BOSTON SCIENTIFIC CORPORATION DISTRIBUTES PROMUS AS ITS OWN BRAND LABELING OF ABBOTT VASCULARS DRUG ELUTING STENT IN THE US. DISSECTION IS A KNOWN ADVERSE EVENT LISTED IN THE PROMUS INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, COULD NOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A PROCEDURE TO TREAT A LESION IN THE RIGHT CORONARY ARTERY WITH MODERATE TORTUOSITY AND MODERATE CALCIFICATION, PRE-DILATATION WAS PERFORMED WITH A NON-ABBOTT BALLOON, AND A 3.5 X 18 PROMUS STENT WAS PLACED SUCCESSFULLY AT THE LESION. AFTER STENT IMPLANTATION, A DISSECTION WAS NOTED; THEREFORE, AN ATTEMPT WAS MADE TO TREAT THE DISSECTION WITH A 3.5 X 12 PROMUS; HOWEVER, THE DEVICE WOULD NOT CROSS THE LESION. THE DISSECTION WAS SUCCESSFULLY TREATED WITH A 3.5 X 12 VISION STENT. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 0071661

Patients

Seq Age Sex Outcome Treatment
1 54 YR Required Intervention